×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AVDL – avadel pharmaceuticals plc - american depositary shares each representing one ordinary share (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AVDL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/3
04:47 pm
avdl
Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting
Low
Report
Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting
12/1
04:05 pm
avdl
Announcement relating to convening of Scheme Meeting and Extraordinary General Meeting
Low
Report
Announcement relating to convening of Scheme Meeting and Extraordinary General Meeting
11/30
06:27 am
avdl
Avadel Pharmaceuticals (AVDL): Evaluating Valuation After Recent Share Price Surge [Yahoo! Finance]
Low
Report
Avadel Pharmaceuticals (AVDL): Evaluating Valuation After Recent Share Price Surge [Yahoo! Finance]
11/20
09:22 am
avdl
Form 8.3 - Avadel Pharmaceuticals plc [Yahoo! Finance]
Low
Report
Form 8.3 - Avadel Pharmaceuticals plc [Yahoo! Finance]
11/20
09:04 am
avdl
Avadel Pharmaceuticals (NASDAQ:AVDL) was given a new $22.50 price target on by analysts at Wells Fargo & Company.
Low
Report
Avadel Pharmaceuticals (NASDAQ:AVDL) was given a new $22.50 price target on by analysts at Wells Fargo & Company.
11/19
01:16 pm
avdl
Avadel Pharmaceuticals (NASDAQ:AVDL) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Avadel Pharmaceuticals (NASDAQ:AVDL) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
11/19
12:05 am
avdl
Needham Reiterates a Hold Rating on Avadel Pharmaceuticals (AVDL) [Yahoo! Finance]
Low
Report
Needham Reiterates a Hold Rating on Avadel Pharmaceuticals (AVDL) [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
8/7/2025
07:00 am
AVDL
avadel pharmaceuticals plc - american depositary shares each representing one ordinary share
BEAT
Report
14.8%
avadel pharmaceuticals plc - american depositary shares each representing one ordinary share
5/7/2025
07:00 am
AVDL
avadel pharmaceuticals plc - american depositary shares each representing one ordinary share
BEAT
Report
5.7%
avadel pharmaceuticals plc - american depositary shares each representing one ordinary share
3/3/2025
07:00 am
AVDL
avadel pharmaceuticals plc - american depositary shares each representing one ordinary share
IN-LINE
Report
-13.5%
avadel pharmaceuticals plc - american depositary shares each representing one ordinary share
3/3/2025
07:00 am
AVDL
avadel pharmaceuticals plc - american depositary shares each representing one ordinary share
IN-LINE
Report
-13.5%
avadel pharmaceuticals plc - american depositary shares each representing one ordinary share
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/3
04:18 pm
avdl
Form DEFM14A AVADEL PHARMACEUTICALS
Low
Report
Form DEFM14A AVADEL PHARMACEUTICALS
12/2
06:04 am
avdl
Form PRER14A AVADEL PHARMACEUTICALS
Low
Report
Form PRER14A AVADEL PHARMACEUTICALS
11/19
07:06 am
avdl
Form DEFA14A AVADEL PHARMACEUTICALS
Low
Report
Form DEFA14A AVADEL PHARMACEUTICALS
11/19
06:24 am
avdl
Form DEFA14A AVADEL PHARMACEUTICALS
Low
Report
Form DEFA14A AVADEL PHARMACEUTICALS
11/19
06:24 am
avdl
Form 8-K AVADEL PHARMACEUTICALS For: Nov 18
Low
Report
Form 8-K AVADEL PHARMACEUTICALS For: Nov 18
11/17
06:57 am
avdl
Form DEFA14A AVADEL PHARMACEUTICALS
Low
Report
Form DEFA14A AVADEL PHARMACEUTICALS
11/17
06:11 am
avdl
Form DEFA14A AVADEL PHARMACEUTICALS
Low
Report
Form DEFA14A AVADEL PHARMACEUTICALS
11/17
06:08 am
avdl
Form 8-K AVADEL PHARMACEUTICALS For: Nov 17
Low
Report
Form 8-K AVADEL PHARMACEUTICALS For: Nov 17
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/21
Avadel Pharmaceuticals Announces $65 Million Private Placement with Leading Biotech Investment Funds
32.0%
6/13 Form 8-K AVADEL PHARMACEUTICALS For: Jun 13 20.4%
6/5 Form 8-K AVADEL PHARMACEUTICALS For: May 30 20.0%
3/24 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $7.75 price target on the stock. 18.2%
9/23 Avadel Pharmaceuticals Announces FDA Agreement to Reduce the Sample Size for the Ongoing Pivotal Phase 3 Study for Once-Nightly FT218; Full Enrollment Now Expected by End of 2019 17.6%
6/10 Form 8-K AVADEL PHARMACEUTICALS For: Jun 04 17.0%
5/24 Form 4 AVADEL PHARMACEUTICALS For: May 22 Filed by: Ende Eric J 15.5%
9/17 Avadel Pharmaceuticals to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24th 15.4%
11/19 Form 4 AVADEL PHARMACEUTICALS For: Nov 15 Filed by: Ende Eric J 14.3%
4/27 Form DEF 14A AVADEL PHARMACEUTICALS For: Aug 05 13.4%
6/13 Form 8-K AVADEL PHARMACEUTICALS For: Jun 13 20.4%
6/5 Form 8-K AVADEL PHARMACEUTICALS For: May 30 20.0%
3/24 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $7.75 price target on the stock. 18.2%
9/23 Avadel Pharmaceuticals Announces FDA Agreement to Reduce the Sample Size for the Ongoing Pivotal Phase 3 Study for Once-Nightly FT218; Full Enrollment Now Expected by End of 2019 17.6%
6/10 Form 8-K AVADEL PHARMACEUTICALS For: Jun 04 17.0%
5/24 Form 4 AVADEL PHARMACEUTICALS For: May 22 Filed by: Ende Eric J 15.5%
9/17 Avadel Pharmaceuticals to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24th 15.4%
11/19 Form 4 AVADEL PHARMACEUTICALS For: Nov 15 Filed by: Ende Eric J 14.3%
4/27 Form DEF 14A AVADEL PHARMACEUTICALS For: Aug 05 13.4%
TOP News Decliners
3/12
Q4/2019 12/31/2019 EPS -0.070 ZacksConsensus -0.250 ActVsEst 0.180 - Beat
-20.7%
4/27 Form 8-K AVADEL PHARMACEUTICALS For: Apr 27 -14.9%
4/28 Avadel Pharmaceuticals Announces Pricing of Public Offering -12.1%
8/8 Avadel Pharmaceuticals Receives New PDUFA Date for AV001 of December 15, 2019 -11.4%
7/2 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -9.8%
6/3 Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Executive Officer -8.8%
9/25 Form 8-K AVADEL PHARMACEUTICALS For: Sep 25 -8.7%
11/12 Form 8-K AVADEL PHARMACEUTICALS For: Nov 12 -8.3%
10/2 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -8.0%
8/30 Fresenius Kabi Introduces Phenylephrine Hydrochloride Injection, USP -7.4%
4/27 Form 8-K AVADEL PHARMACEUTICALS For: Apr 27 -14.9%
4/28 Avadel Pharmaceuticals Announces Pricing of Public Offering -12.1%
8/8 Avadel Pharmaceuticals Receives New PDUFA Date for AV001 of December 15, 2019 -11.4%
7/2 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -9.8%
6/3 Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Executive Officer -8.8%
9/25 Form 8-K AVADEL PHARMACEUTICALS For: Sep 25 -8.7%
11/12 Form 8-K AVADEL PHARMACEUTICALS For: Nov 12 -8.3%
10/2 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -8.0%
8/30 Fresenius Kabi Introduces Phenylephrine Hydrochloride Injection, USP -7.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: